Core Laboratories N.V. (CLB): Price and Financial Metrics


Core Laboratories N.V. (CLB): $25.60

-0.31 (-1.20%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CLB POWR Grades


  • Quality is the dimension where CLB ranks best; there it ranks ahead of 80.1% of US stocks.
  • CLB's strongest trending metric is Growth; it's been moving down over the last 163 days.
  • CLB ranks lowest in Sentiment; there it ranks in the 0th percentile.

CLB Stock Summary

  • The price/operating cash flow metric for Core Laboratories N V is higher than 94.24% of stocks in our set with a positive cash flow.
  • Over the past twelve months, CLB has reported earnings growth of -167.7%, putting it ahead of just 12.11% of US stocks in our set.
  • As for revenue growth, note that CLB's revenue has grown -13.47% over the past 12 months; that beats the revenue growth of just 12.11% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to Core Laboratories N V, a group of peers worth examining would be CHH, STKL, VVNT, PLXS, and OSW.
  • CLB's SEC filings can be seen here. And to visit Core Laboratories N V's official web site, go to www.corelab.com.

CLB Valuation Summary

  • In comparison to the median Energy stock, CLB's EV/EBIT ratio is 44.9% higher, now standing at 26.3.
  • Over the past 243 months, CLB's price/sales ratio has gone up 1.5.
  • Over the past 243 months, CLB's EV/EBIT ratio has gone up 13.

Below are key valuation metrics over time for CLB.

Stock Date P/S P/B P/E EV/EBIT
CLB 2021-09-03 2.9 8.6 39.6 26.3
CLB 2021-09-02 2.9 8.7 39.9 26.4
CLB 2021-09-01 2.9 8.5 38.9 25.9
CLB 2021-08-31 2.9 8.5 39.1 26.0
CLB 2021-08-30 2.9 8.7 39.9 26.4
CLB 2021-08-27 3.0 8.9 41.0 27.1

CLB Growth Metrics

    Its 2 year net cashflow from operations growth rate is now at -26.54%.
  • Its 2 year revenue growth rate is now at -3.07%.
  • The 3 year price growth rate now stands at -49.03%.
CLB's revenue has moved down $178,637,000 over the prior 49 months.

The table below shows CLB's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 458.862 17.579 30.576
2021-06-30 446.259 26.32 32.665
2021-03-31 443.25 43.83 18.889
2020-12-31 487.267 57.868 -97.637
2020-09-30 530.296 91.016 -100.844
2020-06-30 598.114 96.312 -80.078

CLB's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CLB has a Quality Grade of B, ranking ahead of 82.88% of graded US stocks.
  • CLB's asset turnover comes in at 0.785 -- ranking 22nd of 136 Petroleum and Natural Gas stocks.
  • CKX, RES, and NESR are the stocks whose asset turnover ratios are most correlated with CLB.

The table below shows CLB's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.785 0.218 0.083
2021-06-30 0.762 0.223 0.090
2021-03-31 0.752 0.224 0.064
2020-12-31 0.805 0.231 -0.109
2020-09-30 0.808 0.237 -0.107
2020-06-30 0.847 0.248 -0.076

CLB Price Target

For more insight on analysts targets of CLB, see our CLB price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $30.85 Average Broker Recommendation 1.95 (Hold)

CLB Stock Price Chart Interactive Chart >

Price chart for CLB

CLB Price/Volume Stats

Current price $25.60 52-week high $49.87
Prev. close $25.84 52-week low $21.08
Day low $25.16 Volume 8,928
Day high $25.74 Avg. volume 338,707
50-day MA $24.69 Dividend yield 0.15%
200-day MA $30.49 Market Cap 1.19B

Core Laboratories N.V. (CLB) Company Bio


Core Laboratories provides proprietary and patented reservoir description, production enhancement, and reservoir management services used to optimize petroleum reservoir performance. The company was founded in 1936 and is based in Amsterdam, the Netherlands.


CLB Latest News Stream


Event/Time News Detail
Loading, please wait...

CLB Latest Social Stream


Loading social stream, please wait...

View Full CLB Social Stream

Latest CLB News From Around the Web

Below are the latest news stories about Core Laboratories N V that investors may wish to consider to help them evaluate CLB as an investment opportunity.

Morgan Stanley Keeps Their Hold Rating on Core Laboratories (CLB)

Morgan Stanley analyst Connor Lynagh maintained a Hold rating on Core Laboratories (CLB – Research Report) today and set a price target of $30.00. The company's shares closed last Tuesday at $27.38. According to TipRanks.com, Lynagh has 0 stars on 0-5 stars ranking scale with an average return of -5.2% and a 51.0% success rate. Lynagh covers the Industrial Goods sector, focusing on stocks such as Nextier Oilfield Solutions, Liberty Oilfield Services, and Helmerich & Payne. Currently, the analyst consensus on Core Laboratories is a Hold with an average price target of $28.00. See the top stocks recommended by analysts >> The company has a one-year high of $49.

Howard Kim on TipRanks | January 18, 2022

Mraz, Amerine & Associates, Inc. Buys Vanguard Short-Term Inflation-Protected Securities, ...

Modesto, CA, based Investment company Mraz, Amerine & Associates, Inc. (Current Portfolio) buys Vanguard Short-Term Inflation-Protected Securities, Coterra Energy Inc, Core Laboratories NV, Dimensional U.S.

Yahoo | January 14, 2022

ExxonMobil (XOM) to Divest Iraq Assets After Receiving Approval

ExxonMobil's (XOM) divestment of its West Qurna 1 stake would follow its 32% interest sale last year in a key exploration block in Iraq's Kurdistan region.

Yahoo | January 7, 2022

Why ExxonMobil, Occidental Petroleum, and Core Laboratories Surged Double Digits This Week

Shares of ExxonMobil (NYSE: XOM), Occidental Petroleum (NYSE: OXY), and Core Laboratories (NYSE: CLB) rose sharply this week, with these stocks up 11.6%, 13.2%, and 14.3% on the week, respectively, as of 3 p.m. ET on Thursday. Better news about the omicron coronavirus variant, strong U.S. jobs growth, and a drama-free OPEC+ meeting all boosted sentiment for demand, pointing to a scenario in which the omicron variant's impact on the economy would likely be less than feared. More good economic news arrived in Wednesday's December private payroll number, which also came in stronger than expected.

Yahoo | January 7, 2022

CORE LABORATORIES' FOURTH QUARTER 2021 WEBCAST AT 7:30 A.M. CST / 2:30 P.M. CET ON FEBRUARY 3, 2022

Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its fourth quarter 2021 conference call over the Internet at 7:30 a.m. CST / 2:30 p.m. CET on February 3, 2022.

Yahoo | January 4, 2022

Read More 'CLB' Stories Here

CLB Price Returns

1-mo N/A
3-mo -7.41%
6-mo -27.14%
1-year -27.53%
3-year -60.86%
5-year -77.58%
YTD 14.75%
2021 -15.73%
2020 -29.05%
2019 -34.35%
2018 -44.49%
2017 -6.83%

CLB Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full CLB Dividend History

Continue Researching CLB

Want to see what other sources are saying about Core Laboratories N V's financials and stock price? Try the links below:

Core Laboratories N V (CLB) Stock Price | Nasdaq
Core Laboratories N V (CLB) Stock Quote, History and News - Yahoo Finance
Core Laboratories N V (CLB) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9276 seconds.